<DOC>
	<DOC>NCT00469170</DOC>
	<brief_summary>The proposed study is a multi-centre, open-label crossover study to assess the safety and acceptability of a silicone elastomer vaginal ring (containing no drug) when inserted for a 12 week period in 200 healthy, sexually active women.</brief_summary>
	<brief_title>A Safety and Acceptability Study of a Vaginal Ring Microbicide Delivery Method</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>Female, age 1835 years Willing and able to provide written informed consent HIVuninfected and otherwise healthy Selfreported sexually active On a stable hormonal contraceptive regimen Regular menstrual cycle Willing to refrain from use of vaginal products or objects during the study Currently pregnant or last pregnancy within 3 months prior to enrollment Currently breastfeeding Participated in any other research study within 30 days prior to enrollment; Symptomatic untreated vaginal infections within 2 weeks prior to enrollment Presence of abnormal physical finding on the vulva, vaginal walls or cervix History of significant urogenital or uterine prolapse, undiagnosed vaginal bleeding, urethral obstruction; Pap smear result at screening that requires cryotherapy, biopsy, treatment (other than for infection), or further evaluation Unexplained, undiagnosed abnormal bleeding per vagina, bleeding per vagina during or following vaginal intercourse, or gynecologic surgery within 90 days prior to enrollment Any serious acute, chronic or progressive disease</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>HIV-1</keyword>
	<keyword>HIV seronegativity</keyword>
</DOC>